Ebdarokimab (Anti-IL-12b)
Ebdarokimab (Anti-IL-12b) (A2842-GRP)
Products
Description
Ebdarokimab (Anti-IL-12b) is a fully human monoclonal antibody (mAb) targeting Interleukin-12/Interleukin-23 (IL-12/IL-23) pathway. Ebdarokimab has the potential to treat moderate to severe plaque psoriasis. MW : 145.6 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2842 |
| Target | Interleukins |